UniProt ID | FOSL2_HUMAN | |
---|---|---|
UniProt AC | P15408 | |
Protein Name | Fos-related antigen 2 | |
Gene Name | FOSL2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 326 | |
Subcellular Localization | Nucleus. | |
Protein Description | Controls osteoclast survival and size. As a dimer with JUN, activates LIF transcription. Activates CEBPB transcription in PGE2-activated osteoblasts.. | |
Protein Sequence | MYQDYPGNFDTSSRGSSGSPAHAESYSSGGGGQQKFRVDMPGSGSAFIPTINAITTSQDLQWMVQPTVITSMSNPYPRSHPYSPLPGLASVPGHMALPRPGVIKTIGTTVGRRRRDEQLSPEEEEKRRIRRERNKLAAAKCRNRRRELTEKLQAETEELEEEKSGLQKEIAELQKEKEKLEFMLVAHGPVCKISPEERRSPPAPGLQPMRSGGGSVGAVVVKQEPLEEDSPSSSSAGLDKAQRSVIKPISIAGGFYGEEPLHTPIVVTSTPAVTPGTSNLVFTYPSVLEQESPASPSESCSKAHRRSSSSGDQSSDSLNSPTLLAL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MYQDYPGN -------CCCCCCCC | 6.47 | 22814378 | |
2 | Phosphorylation | ------MYQDYPGNF ------CCCCCCCCC | 15.30 | 23401153 | |
5 | Phosphorylation | ---MYQDYPGNFDTS ---CCCCCCCCCCCC | 9.49 | 23401153 | |
11 | Phosphorylation | DYPGNFDTSSRGSSG CCCCCCCCCCCCCCC | 25.19 | 23401153 | |
12 | Phosphorylation | YPGNFDTSSRGSSGS CCCCCCCCCCCCCCC | 21.63 | 23401153 | |
13 | Phosphorylation | PGNFDTSSRGSSGSP CCCCCCCCCCCCCCC | 42.63 | 23401153 | |
16 | Phosphorylation | FDTSSRGSSGSPAHA CCCCCCCCCCCCCCC | 30.34 | 22167270 | |
17 | Phosphorylation | DTSSRGSSGSPAHAE CCCCCCCCCCCCCCC | 46.22 | 22167270 | |
19 | Phosphorylation | SSRGSSGSPAHAESY CCCCCCCCCCCCCCC | 22.36 | 22167270 | |
25 | Phosphorylation | GSPAHAESYSSGGGG CCCCCCCCCCCCCCC | 30.97 | 22167270 | |
26 | Phosphorylation | SPAHAESYSSGGGGQ CCCCCCCCCCCCCCC | 9.81 | 23927012 | |
27 | Phosphorylation | PAHAESYSSGGGGQQ CCCCCCCCCCCCCCE | 31.61 | 23403867 | |
28 | Phosphorylation | AHAESYSSGGGGQQK CCCCCCCCCCCCCEE | 32.97 | 23403867 | |
35 | Ubiquitination | SGGGGQQKFRVDMPG CCCCCCEEEEEECCC | 27.53 | - | |
35 | Sumoylation | SGGGGQQKFRVDMPG CCCCCCEEEEEECCC | 27.53 | 28112733 | |
55 | O-linked_Glycosylation | IPTINAITTSQDLQW ECEEEEEECCCCHHH | 20.27 | 29485866 | |
56 | O-linked_Glycosylation | PTINAITTSQDLQWM CEEEEEECCCCHHHH | 20.48 | 29485866 | |
57 | O-linked_Glycosylation | TINAITTSQDLQWMV EEEEEECCCCHHHHH | 17.04 | 29485866 | |
67 | O-linked_Glycosylation | LQWMVQPTVITSMSN HHHHHCCEEEECCCC | 13.88 | 29485866 | |
79 | Phosphorylation | MSNPYPRSHPYSPLP CCCCCCCCCCCCCCC | 25.06 | 27794612 | |
82 | Phosphorylation | PYPRSHPYSPLPGLA CCCCCCCCCCCCCCC | 19.93 | 24732914 | |
83 | Phosphorylation | YPRSHPYSPLPGLAS CCCCCCCCCCCCCCC | 25.14 | 25159151 | |
90 | Phosphorylation | SPLPGLASVPGHMAL CCCCCCCCCCCCCCC | 33.61 | 24732914 | |
104 | Ubiquitination | LPRPGVIKTIGTTVG CCCCCCEEECCCHHC | 31.51 | - | |
104 | Acetylation | LPRPGVIKTIGTTVG CCCCCCEEECCCHHC | 31.51 | 23236377 | |
104 | Methylation | LPRPGVIKTIGTTVG CCCCCCEEECCCHHC | 31.51 | - | |
104 | "N6,N6-dimethyllysine" | LPRPGVIKTIGTTVG CCCCCCEEECCCHHC | 31.51 | - | |
104 | Sumoylation | LPRPGVIKTIGTTVG CCCCCCEEECCCHHC | 31.51 | 28112733 | |
120 | Phosphorylation | RRRDEQLSPEEEEKR CHHCCCCCHHHHHHH | 29.93 | 23401153 | |
151 | Acetylation | RRRELTEKLQAETEE HHHHHHHHHHHHHHH | 40.44 | 26051181 | |
151 | Ubiquitination | RRRELTEKLQAETEE HHHHHHHHHHHHHHH | 40.44 | - | |
163 | Acetylation | TEELEEEKSGLQKEI HHHHHHHHHHHHHHH | 53.77 | 26051181 | |
168 | Ubiquitination | EEKSGLQKEIAELQK HHHHHHHHHHHHHHH | 57.01 | - | |
194 | Phosphorylation | HGPVCKISPEERRSP CCCEEECCHHHHCCC | 16.26 | 28355574 | |
200 | Phosphorylation | ISPEERRSPPAPGLQ CCHHHHCCCCCCCCC | 41.26 | 29255136 | |
211 | Phosphorylation | PGLQPMRSGGGSVGA CCCCCCCCCCCCEEE | 35.22 | 30266825 | |
215 | Phosphorylation | PMRSGGGSVGAVVVK CCCCCCCCEEEEEEE | 22.20 | 23927012 | |
222 | Sumoylation | SVGAVVVKQEPLEED CEEEEEEECCCCCCC | 37.02 | 25114211 | |
222 | Sumoylation | SVGAVVVKQEPLEED CEEEEEEECCCCCCC | 37.02 | - | |
222 | Acetylation | SVGAVVVKQEPLEED CEEEEEEECCCCCCC | 37.02 | 23236377 | |
230 | Phosphorylation | QEPLEEDSPSSSSAG CCCCCCCCCCCCCCC | 29.93 | 22167270 | |
232 | Phosphorylation | PLEEDSPSSSSAGLD CCCCCCCCCCCCCCC | 46.97 | 22167270 | |
233 | Phosphorylation | LEEDSPSSSSAGLDK CCCCCCCCCCCCCCH | 31.53 | 22167270 | |
234 | Phosphorylation | EEDSPSSSSAGLDKA CCCCCCCCCCCCCHH | 28.66 | 22167270 | |
235 | Phosphorylation | EDSPSSSSAGLDKAQ CCCCCCCCCCCCHHH | 28.44 | 22167270 | |
240 | Acetylation | SSSAGLDKAQRSVIK CCCCCCCHHHHHCCC | 52.00 | 26051181 | |
240 | Ubiquitination | SSSAGLDKAQRSVIK CCCCCCCHHHHHCCC | 52.00 | - | |
240 | Sumoylation | SSSAGLDKAQRSVIK CCCCCCCHHHHHCCC | 52.00 | 28112733 | |
263 | O-linked_Glycosylation | YGEEPLHTPIVVTST CCCCCCCCCEEEECC | 23.53 | 29485866 | |
269 | O-linked_Glycosylation | HTPIVVTSTPAVTPG CCCEEEECCCCCCCC | 22.30 | 29485866 | |
270 | O-linked_Glycosylation | TPIVVTSTPAVTPGT CCEEEECCCCCCCCC | 13.10 | 29485866 | |
292 | Phosphorylation | PSVLEQESPASPSES HHHHCCCCCCCCCHH | 26.01 | 25137130 | |
295 | Phosphorylation | LEQESPASPSESCSK HCCCCCCCCCHHHHH | 32.13 | 26657352 | |
307 | Phosphorylation | CSKAHRRSSSSGDQS HHHHHHHCCCCCCCC | 34.23 | 30266825 | |
308 | Phosphorylation | SKAHRRSSSSGDQSS HHHHHHCCCCCCCCC | 27.06 | 30266825 | |
309 | Phosphorylation | KAHRRSSSSGDQSSD HHHHHCCCCCCCCCC | 39.32 | 30266825 | |
310 | Phosphorylation | AHRRSSSSGDQSSDS HHHHCCCCCCCCCCC | 48.62 | 30266825 | |
314 | Phosphorylation | SSSSGDQSSDSLNSP CCCCCCCCCCCCCCC | 40.63 | 22167270 | |
315 | Phosphorylation | SSSGDQSSDSLNSPT CCCCCCCCCCCCCCC | 26.11 | 22167270 | |
317 | Phosphorylation | SGDQSSDSLNSPTLL CCCCCCCCCCCCCEE | 31.25 | 30266825 | |
320 | Phosphorylation | QSSDSLNSPTLLAL- CCCCCCCCCCEECC- | 25.26 | 30266825 | |
322 | Phosphorylation | SDSLNSPTLLAL--- CCCCCCCCEECC--- | 33.94 | 30266825 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FOSL2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FOSL2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200; SER-211; SER-215AND SER-230, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-120; SER-200;SER-230; SER-308 AND SER-320, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200 AND SER-230, ANDMASS SPECTROMETRY. |